5-fluorotryptamine has been researched along with indopan in 1 studies
| Studies (5-fluorotryptamine) | Trials (5-fluorotryptamine) | Recent Studies (post-2010) (5-fluorotryptamine) | Studies (indopan) | Trials (indopan) | Recent Studies (post-2010) (indopan) |
|---|---|---|---|---|---|
| 15 | 0 | 4 | 56 | 1 | 16 |
| Protein | Taxonomy | 5-fluorotryptamine (IC50) | indopan (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.7153 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.3442 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.8621 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, MH; Blough, BE; Decker, AM; Landavazo, A; Page, KM; Partilla, JS; Rothman, RB | 1 |
1 other study(ies) available for 5-fluorotryptamine and indopan
| Article | Year |
|---|---|
Alpha-ethyltryptamines as dual dopamine-serotonin releasers.
Topics: Dopamine; Dose-Response Relationship, Drug; Humans; Molecular Structure; Norepinephrine; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship; Tryptamines | 2014 |